Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison between Masport and Dysport in facial Botox
IRCT20230727058942N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Aug 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of botulinum toxin type A and abobotulinumtoxinA in rhytides, periocular rhytides and Forehead lines (2 arms), sponsored by Tehran University of Medical Sciences. Started Aug 2023; status: completed.
02
Drugs
botulinum toxin type AabobotulinumtoxinA
03
Conditions
rhytidesperiocular rhytidesForehead lines
Beyond the preview
Go deeper on IRCT20230727058942N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230727058942N1.